Skip to main content
Year archive

Deutsche Biotech Innovativ AG — 2015 filings

All 10 regulatory filings released by Deutsche Biotech Innovativ AG (DBI) in 2015, sourced directly from the official regulator.

10 Filings
2015 Period
2015 filings (10)
Filing Released Lang
Deutsche Biotech Innovativ AG invests funds from capital increase in clinical development of sepsis drug Adrecizumab
Share Issue/Capital Change
2015-11-25 English
Deutsche Biotech Innovativ AG: First public offer to private investors
Capital/Financing Update
2015-10-29 English
Deutsche Biotech Innovativ AG: Deutsche Biotech Innovativ AG launches capital increase and offers shares to the public for the first time
Capital/Financing Update
2015-10-09 English
Deutsche Biotech Innovativ AG: Subscrition price for capital increase against cash contribution fixed at EUR 33.50
Share Issue/Capital Change
2015-09-25 English
Deutsche Biotech Innovativ AG: First Berlin starts coverage with EUR 67.90 price target
Earnings Release FY 2015
2015-09-09 English
Deutsche Biotech Innovativ AG: Sepsis drug Adrecizumab shows high degree of efficacy in preclinical studies
Regulatory Filings
2015-08-06 English
Deutsche Biotech Innovativ AG: AGM approves bonus shares and capital increase
AGM Information
2015-07-24 English
Deutsche Biotech Innovativ AG: Significant strengthening of the patent protection for the sepsis drug candidate Adrecizumab
Regulatory Filings
2015-07-21 English
Deutsche Biotech Innovativ AG: Successful further development of sepsis and cancer drugs
Earnings Release FY 2014
2015-06-12 English
Deutsche Biotech Innovativ AG: Erfolgreiche Kapitalerhohung und Portfolioerweiterung
Share Issue/Capital Change
2015-01-22 German